Rise in Prevalence of Airborne Diseases and Increasing Pollution to Propel the Biodetection Market Growth
Global Biodetection Market, by Type of Product and Services (by Product (Bioanalyses, Instruments, Reagents and Media, and Accessories and Consumables) and by Services (Bioanalyses, Chemical Analyses, and DNA Based Analyses)), by Application (Defence, Food and Environment, and Clinical), and by Region (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2023-2030
According
to Coherent Market Insights the Biodetection
Market Global Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2022-2028. as highlighted in a new report published by Coherent
Market Insights.
Market Overview:
Biodetection
is a term that encompasses global strategies for detecting biological threats
such as pathogens, infectious diseases, and biological weapons. Biodetection is
widely used for diagnosing disease or infection, point-of-care monitoring and
treatment, environmental monitoring, forensics and research, and detecting
toxins. The use of biodetectors and accessories in point-of-care testing helps
in quick detection of analytes near to patients and better disease diagnosis,
monitoring, and management. The technology plays a key role in future
biomedicine and healthcare.
Competitive Landscape:
Major
players operating in the global biodetection market are Smith Group Plc., Cepheid Inc., Agilent Technologies,
Roche Diagnostics, BioDetection Systems B.V., and Dycor Technologies Ltd.,
among others.
Key Market Drivers:
Increasing
prevalence of airborne diseases and increasing pollution across the globe is
expected to boost growth of the global biodetection market during the forecast period. For instance, as per the World
Health Organization (WHO), the combined effects of ambient air pollution and
household air pollution are associated with 6.7 million premature deaths
annually. Household air pollution exposure leads to noncommunicable diseases
such as stroke, ischaemic heart disease, lung cancer, and chronic obstructive
pulmonary disease (COPD).
Moreover,
misuse of biological agents and weapons across the world is expected to boost
growth of the global biodetection market.
For instance, according to WHO, biological and toxin weapons are either
microorganisms such as virus, bacteria or fungi, or toxic substances produced
by living organisms that are produced and released deliberately to cause
disease and death in humans, plants, and animals. This in turn is rising the
use of biodetection worldwide.
COVID-19 Impact
Analysis:
In
response to the COVID-19 crisis, demand for biodetectors and accessories
significantly soared with increase in regulatory support towards preventive
measures and initiating clinical urgency for procuring biodefense mechanisms.
For instance, in February 2021, Smiths Detection launched the biological
identifier, BioFlash, to detect SARS-CoV-2 (COVID-19) virus in the air
following tests performed by the U.S. Army Medical Research Institute of
Infectious Diseases (AMRIID). This in turn is driving the growth of the market.
Key Takeaways:
· The market is expected
to exhibit a CAGR of XX % during the forecast period due to the increasing
demand for technologically advanced instruments for enhanced and early
detection of bio threats. For instance, in January 2023, MeitY launched the Technology for
Biosensing system for the detection of Endocrine Disrupting Chemicals in
aquatic ecosystems (MEAN) developed under MeitY-supported projects. MeitY developed
a biosensing system for detection of Endocrine Disrupting Chemicals (EDC) in
aquatic ecosystems, for qualitative and quantitative analysis of EDC content in
water bodies.
· Among regions, Asia
Pacific is expected to witness robust growth in the market due to the rise in prevalence of airborne diseases and
increasing pollution, misuse of biological agents and weapons, and increase in
demand for technologically advanced devices or tools for enhanced and early
detection of bio threats in the region.
For instance, India has cautioned over the
“heightened” threat of misuse of biological agents and chemicals as weapons
against the backdrop of the COVID-19 pandemic and called on the international
community to address the rapid evolution of proliferation risks. The access to
these weapons of mass destruction by terrorists and other non-state actors adds
a serious dimension to threats posed by these weapons to international peace and
security, A. Amarnath, a counsellor at India's UN Mission said.
Comments
Post a Comment